News | Peripheral Artery Disease (PAD) | May 17, 2017

Contego Medical Receives CE Mark for Vanguard IEP Peripheral Balloon Angioplasty System

System features distal embolic filter on peripheral angioplasty balloon to protect the lower limbs without additional devices or exchanges

Contego Medical Receives CE Mark for Vanguard IEP Peripheral Balloon Angioplasty System

May 17, 2017 — Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection (IEP). The company intends to launch the Vanguard IEP System in Europe to endovascular specialists performing lower limb angioplasty procedures.

The Vanguard IEP System represents the latest innovation of Contego's IEP technology, incorporating a peripheral angioplasty balloon and distal embolic filter on the same catheter. The system protects the lower limbs during angioplasty without the need for additional devices or exchanges. The Vanguard IEP System has an over-the-wire design with a sheathless integrated 150-micron pore filter distal to the angioplasty balloon. It is the first filter to feature in-vivo adjustability to suit varying vessel sizes and maximize capture efficiency.

"The Vanguard IEP System is an important step toward enhancing safety for patients undergoing peripheral angioplasty for occlusive disease," said Prof. Thomas Zeller, director of the Department of Angiology at Universitaets-Herzzentrum Freiburg in Bad Krozingen, Germany and principal investigator of the upcoming Vanguard clinical study. "This device will be of particular importance to patients at high risk for distal embolization, such as those with acute limb ischemia or chronic total occlusions, as well as those at higher risk should embolization occur, such as patients with critical limb ischemia and diabetes mellitus."

Contego has established a premier distribution network throughout Europe to sell the Vanguard IEP System. Their first IEP device, the Paladin Carotid Post-Dilation Balloon System was launched in Europe in 2016.

For more information: www.contegomedical.com

Related Content

Abbott recalls its NC Balloon catheters
News | Balloon Catheter| May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter| November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter| March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter| January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter| October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init